App Store

Google Play

Copy of Device Banner Block 894x1036 3

Descubre un mundo infinito de historias

Escucha y lee

Bloomberg


Bloomberg's Joe Weisenthal and Tracy Alloway explore the most interesting topics in finance, markets and economics. Join the conversation every Monday and Thursday.


Odd Lots

These days, there's a non-stop drumbeat of concern that China and its dominant companies will eat America's economic lunch, so to speak. Of course, this isn't the first time in our history that there were worries about a rising Asian industrial power. In the 1980s and early 1990s, there was a lot of concern about the rise of corporate Japan. And that fear was seen all over movies and pop culture, from Die Hard to the Michael Crichton novel Rising Sun. This time there is one big difference: Chinese dominance doesn't permeate our pop culture in the same way. And furthermore, the US has long had military bases in Japan, so that dimension was quite different, too. To understand this period further, we talk to John Ganz, who writes the Unpopular Front newsletter, and is the author of the recent book, When the Clock Broke: Con Men, Conspiracists, and How America Cracked Up in the Early 1990s. We discuss how this fear came about and disappeared, but also how it still influences American politics to this day.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

John Ganz on the Era When America Was Consumed by Panic With Corporate Japan

What changed between 2019 and 2025? Why are interest rates so much higher? Why does it seem virtually unfathomable that the Fed will return to ZIRP anytime soon? Why do investors expect this rate cut cycle to be so shallow? The answer, theoretically, is that the neutral rate of interest has gone up. But what is the neutral rate of interest, and why has it moved? On this episode, we speak with Jamie Rush of Bloomberg Economics and Tom Orlik, the Chief Economist at Bloomberg Economics. They, along with Bloomberg's Stephanie Flanders, are the editors of a new book titled The Price of Money: A Guide to the Past, Present, and Future of the Natural Rate of Interest, in which they attempt to directly identify what the neutral rate of interest actually is. We discuss the big changes over the last several years, including deglobalization, demographics, and datacenters, that are pushing this number higher.

Listen to our sister show Trumponomics: Trump Isn’t the Only Reason the Price of Money Is Rising
Read more:
Trump’s Contradiction: Demanding Steep Rate Cuts for a ‘Booming’ Economy
Fed Set to Drive Global Rate Cuts as Europe Shifts to Pause
 
Only http://Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox each week, plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Why the Price of Money Surged in the Last 6 Years

Money has been flowing into the AI space, with billions pouring into GPU clusters, data centers, gas turbines, and the infrastructure needed to train and deploy bigger and bigger models. So what comes next? On this episode, we speak with James van Geelen, founder of Citrini Research. We talk to him about his latest field trip to one of OpenAI's new massive Stargate data centers in Abilene, Texas. We also discuss the increasingly complicated financing arrangements that are funding some of these mega projects and the energy needed to power them. Finally, we ask the question which everyone seems to be asking right now: is AI in a bubble?
 
Read more:
OpenAI Valuation Reaches $500 Billion, Topping Musk’s SpaceX
FOMO Builds as Alibaba Extends $250 Billion AI-Fueled Comeback
 
Only http://Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox each week, plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

James van Geelen on the Next Phase of the AI Buildout

We're used to talking about the Federal Reserve changing "benchmark interest rates." But the mechanics of how the central bank actually tightens or loosens policy are a lot more nuanced. For years now, the Fed's been doing this through the federal funds market — where US banks lend and borrow their excess reserves. But that could be changing. Last week, Dallas Fed President Lorie Logan argued that the fed funds target is outdated, and the central bank should be looking at alternatives. So what would those alternatives actually look like, and why do the intricacies of these short-term funding markets actually matter? We speak with Joe Abate, head of macrostrategy, at SMBC Nikko about this and the broader liquidity picture.
 
Read More: Logan Ushers in New Era of Debate on Fed’s Key Policy Tool 
 
Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Lots More with Joe Abate on the Fed's New Target and the Rising Price of Money

CME Group is one of the oldest exchanges around, tracing it's history all the way back to the late 1800s, when it specialized in agricultural commodities. It's best known for things like futures and interest rate swaps that tend to be favored by professional traders. But as retail trading becomes big business, the CME is expanding its footprint in the space, including a recently-announced partnership with sports-betting platform FanDuel. So how does a marketplace that built its reputation on professional hedging and risk management now try to capture the attention of everyday investors? In this episode we speak with Terry Duffy, CME Group chairman and CEO, about the exchange’s push into retail, new competition in the Treasury futures space, and much more.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Terry Duffy on the CME's Big Push into Retail Trading

For over 20 years, people have been talking about prediction markets or event markets are the next big thing. But mostly, with some niche exceptions, they haven't taken off, in part due to regulatory constraints. But now they seem to be booming, and the regulatory environment has gotten much more friendly. On this live episode recorded in Chicago, we speak with Tarek Mansour, the co-founder and CEO of Kalshi, one of the prediction market platforms that's booming. One reason it's doing so well is because it's gone big into sports, which of course gets into its own regulatory thicket. In this conversation, we talk about the future of these markets, the prospect for markets other than sports and presidential elections, and Kalshi's overall plan to let its users to eventually trade everything.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Tarek Mansour on Kalshi's Plan to Create Markets in Everything

Don Wilson has built a career diving into some of trading’s thorniest problems, including figuring out ways to trade new and niche markets. Now, the founder and CEO of DRW has his sights set on the GPUs powering AI, which he thinks could end up being a bigger market than crude oil. In this episode, which was recorded live onstage at our show in Chicago, we talk about how such a market would work, including ways to ‘standardize’ the vast array of different types of semiconductors, and how this could change the capital stack of the industry. We also talk the evolution of trading over Don’s storied career and why he thinks most assets (and maybe even all of them) will be tokenized within the next five years.
 
Read more:
ASM International Cuts Outlook After Chip Demand Disappoints
Taiwan Pauses South African Chip Export Curbs After Two Days
 
Only Bloomberg - Business News, Stock Markets, Finance, Breaking & World News subscribers can get the Odd Lots newsletter in their inbox each week, plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

The King of Chicago Trading Wants to Build a GPU Market Bigger Than Oil

Kindbody, one of the largest fertility companies in the US, sought to disrupt egg freezing and IVF by combining spa vibes with Silicon Valley efficiency. The startup raised millions, opened dozens of clinics, and became a billion-dollar unicorn. But its ambition came with consequences. In IVF Disrupted: The Kindbody Story, reporter Jackie Davalos takes listeners beyond Kindbody’s millennial-friendly waiting rooms and into the clinics themselves, showing the sometimes-heartbreaking consequences of bringing the “move fast and break things” mentality to the business of creating life.

Visit Bloomberg.com/ivfdistrupted to learn more.

See omnystudio.com/listener for privacy information.

Introducing IVF Disrupted: The Kindbody Story

We know that the top-tier AI labs are spending unbelievable amounts of money on talent. But what are these researchers actually working on? And how do we know that they're making progress? And furthermore, how can we even measure that progress? On this episode, we speak with Jack Morris, an AI researcher and Ph.D. candidate at Cornell University, who is also a part-time researcher at Meta. We talk about what he does, and why breakthroughs seem to be lumpy and unpredictable. We also talk about the battle between open- and closed-source approaches, US vs. Chinese labs, and how an individual talent thinks about where they want to spend their time, balancing the desire for research and prestige with a big fat paycheck.

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Jack Morris on Finding the Next Big AI Breakthrough

There are two huge winning trades that people are looking at day after day. Gold keeps going up and US tech stocks keep going up. But what is driving this intense flow? How long can these consensus trades last? On this episode, we speak with Ozan Tarman, the Vice Chair of Global Macro at Deutsche Bank. As part of his role at the bank, Ozan talks non-stop with hedge funders, sovereign wealth fund managers, and, of course, the analysts at his own bank. This means he has an excellent perspective on why these trades are so popular now. He explains why there is a decline in confidence about the US sovereign (hence the rise in gold) around the world, but also an incredible fixation on the success of the big US tech companies (hence their constant bid). We also talk about other popular consensus trades, from steepeners to Chinese equities to Liz Truss moments all around the world.c
 
Read more:
China Courts Foreign Gold Reserves to Boost Global Clout
Nvidia’s OpenAI Deal Fuels ‘Circular’ Financing Concerns
 
Only Bloomberg subscribers can get the Odd Lots newsletter in their inbox each week, plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Ozan Tarman on What's Driving The Nonstop Rise in Gold and Tech

One of the first moves made by the Trump administration was to change the nature of grants made by the National Institutes of Health. Under the new policy, there's a 15% cap on "indirect costs" associated with a given grant. This is money that essentially pays for institutional overhead, not directly related to the new costs of the specific project itself. So how do NIH grants actually work? What are the direct and indirect costs? What is the effect that's already playing out? On this episode, we speak to Carole LaBonne, a biologist and researcher at Northwestern University, on what she's already seeing from the changes.

Read more:
Trump’s Science Agency Pick Says He Won’t Cut More Personnel
The US Is Withdrawing From Global Health at a Dangerous Time

Odd Lots is coming to Washington, DC! Get your tickets for our Jones Act debate here.

See omnystudio.com/listener for privacy information.

Trump's NIH Cuts Send Shockwaves Through the Science World

Escucha y lee

Otros podcasts que te pueden gustar...